ZNF30
gene geneOn this page
Also known as KOX28DKFZp686N19164FLJ20562
Summary
ZNF30 (zinc finger protein 30, HGNC:13090) is a protein-coding gene on chromosome 19q13.13, encoding Zinc finger protein 30 (P17039). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 90075 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 97 total
- MANE Select transcript:
NM_194325
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13090 |
| Approved symbol | ZNF30 |
| Name | zinc finger protein 30 |
| Location | 19q13.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KOX28, DKFZp686N19164, FLJ20562 |
| Ensembl gene | ENSG00000168661 |
| Ensembl biotype | protein_coding |
| Entrez | 90075 |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 11 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000303586, ENST00000439785, ENST00000595818, ENST00000601142, ENST00000601540, ENST00000601957, ENST00000891913, ENST00000891914, ENST00000932306, ENST00000932307, ENST00000957110, ENST00000957111
RefSeq mRNA: 3 — MANE Select: NM_194325
NM_001099437, NM_001099438, NM_194325
CCDS: CCDS46044, CCDS46045
Canonical transcript exons
ENST00000601142 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001734895 | 34926903 | 34927216 |
| ENSE00003211754 | 34943223 | 34945168 |
| ENSE00003573321 | 34933628 | 34933723 |
| ENSE00003706249 | 34929884 | 34929956 |
| ENSE00003709229 | 34931843 | 34931993 |
Expression profiles
Bgee: expression breadth ubiquitous, 220 present calls, max score 86.07.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 2.6811 / max 43.0608, expressed in 1175 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 175157 | 1.0046 | 564 |
| 175158 | 0.8472 | 483 |
| 175160 | 0.6337 | 354 |
| 175159 | 0.1955 | 82 |
Top tissues by expression
254 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.07 | gold quality |
| secondary oocyte | CL:0000655 | 85.17 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 84.40 | silver quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 83.67 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 83.40 | silver quality |
| middle temporal gyrus | UBERON:0002771 | 82.93 | silver quality |
| cerebellar cortex | UBERON:0002129 | 82.11 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 82.08 | gold quality |
| cerebellum | UBERON:0002037 | 81.67 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 80.60 | gold quality |
| tibia | UBERON:0000979 | 80.28 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.18 | gold quality |
| primary visual cortex | UBERON:0002436 | 79.00 | gold quality |
| endothelial cell | CL:0000115 | 78.67 | gold quality |
| pancreatic ductal cell | CL:0002079 | 78.28 | gold quality |
| cortical plate | UBERON:0005343 | 78.10 | gold quality |
| cerebellar vermis | UBERON:0004720 | 77.34 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 77.30 | gold quality |
| visceral pleura | UBERON:0002401 | 77.16 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 76.80 | gold quality |
| parietal pleura | UBERON:0002400 | 76.49 | gold quality |
| apex of heart | UBERON:0002098 | 75.66 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 74.71 | gold quality |
| ganglionic eminence | UBERON:0004023 | 74.48 | gold quality |
| tendon | UBERON:0000043 | 74.41 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 73.47 | gold quality |
| occipital lobe | UBERON:0002021 | 73.38 | gold quality |
| caudate nucleus | UBERON:0001873 | 73.34 | gold quality |
| right frontal lobe | UBERON:0002810 | 73.13 | gold quality |
| granulocyte | CL:0000094 | 73.11 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-100618 | yes | 651.73 |
| E-ANND-3 | no | 3.81 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
24 targeting ZNF30, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4682 | 100.00 | 68.89 | 1258 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-485-3P | 99.98 | 70.68 | 1585 |
| HSA-MIR-539-3P | 99.98 | 70.74 | 1616 |
| HSA-MIR-23A-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23B-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23C | 99.95 | 73.92 | 3192 |
| HSA-MIR-4307 | 99.82 | 70.45 | 3374 |
| HSA-MIR-3156-3P | 99.76 | 66.72 | 939 |
| HSA-MIR-7159-5P | 99.53 | 72.12 | 2472 |
| HSA-MIR-6727-3P | 99.49 | 65.92 | 1333 |
| HSA-MIR-4762-3P | 99.43 | 69.72 | 2363 |
| HSA-MIR-183-3P | 99.41 | 69.41 | 1598 |
| HSA-MIR-4722-3P | 99.35 | 65.22 | 1099 |
| HSA-MIR-1206 | 99.30 | 69.32 | 1016 |
| HSA-MIR-4705 | 99.10 | 69.10 | 1091 |
| HSA-MIR-4711-5P | 98.89 | 68.00 | 965 |
| HSA-MIR-6512-5P | 98.76 | 69.29 | 1195 |
| HSA-MIR-4266 | 98.53 | 67.29 | 1035 |
| HSA-MIR-338-3P | 98.14 | 67.38 | 1137 |
| HSA-MIR-4303 | 98.01 | 68.13 | 2304 |
| HSA-MIR-634 | 97.74 | 67.11 | 818 |
| HSA-MIR-7112-3P | 97.67 | 68.77 | 948 |
| HSA-MIR-6500-3P | 97.42 | 67.20 | 867 |
Cross-species orthologs
0 orthologs
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 30 — P17039 (reviewed: P17039)
Alternative names: Zinc finger protein KOX28
All UniProt accessions (2): P17039, V9GYJ2
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P17039-1 | 1 | yes |
| P17039-2 | 2 | |
| P17039-3 | 3 |
RefSeq proteins (3): NP_001092907, NP_001092908, NP_919306* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050826 | Krueppel_C2H2_ZnFinger | Family |
Pfam: PF00096, PF01352
UniProt features (34 total): zinc finger region 18, sequence conflict 7, sequence variant 4, splice variant 3, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P17039-F1 | 79.09 | 0.22 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
| R-HSA-9843940 | Regulation of endogenous retroelements by KRAB-ZFP proteins |
MSigDB gene sets: 42 (showing top):
GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, ZWANG_DOWN_BY_2ND_EGF_PULSE, REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, RYBP_TARGET_GENES, UBN1_TARGET_GENES, ZNF2_TARGET_GENES, ZNF30_TARGET_GENES, ZNF512_TARGET_GENES, ZSCAN21_TARGET_GENES, MIR23A_3P_MIR23B_3P, MIR23C, MIR4307, MIR4682, GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_DN
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), sequence-specific DNA binding (GO:0043565), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
| Regulation of endogenous retroelements | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| DNA binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
306 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF30 | SCGB2B2 | Q4G0G5 | 475 |
| ZNF30 | TATDN2 | Q93075 | 370 |
| ZNF30 | PHF8 | Q9UPP1 | 359 |
| ZNF30 | TTK | P33981 | 352 |
| ZNF30 | ZNF385B | Q569K4 | 341 |
| ZNF30 | UBA2 | Q9UBT2 | 323 |
| ZNF30 | C9JR48 | C9JR48 | 322 |
| ZNF30 | ZDHHC8 | Q9ULC8 | 315 |
| ZNF30 | YWHAE | P29360 | 314 |
| ZNF30 | LSM14A | Q8ND56 | 313 |
| ZNF30 | ZC3H4 | Q9UPT8 | 311 |
| ZNF30 | PRSS33 | Q8NF86 | 311 |
| ZNF30 | WTIP | A6NIX2 | 311 |
| ZNF30 | ZNF277 | Q9NRM2 | 305 |
| ZNF30 | POGZ | Q7Z3K3 | 289 |
IntAct
7 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF30 | SPAST | psi-mi:“MI:0915”(physical association) | 0.400 |
| MRFAP1L1 | MYO9A | psi-mi:“MI:0914”(association) | 0.350 |
| CLK2 | CPSF4 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (9): ZNF30 (Affinity Capture-MS), SPAST (Affinity Capture-MS), ZNF30 (Affinity Capture-MS), ZNF30 (Affinity Capture-MS), ZNF30 (Affinity Capture-MS), ZNF30 (Proximity Label-MS), ZNF30 (Cross-Linking-MS (XL-MS)), ZNF30 (Co-fractionation), ZNF30 (Affinity Capture-MS)
ESM2 similar proteins: A2VDQ7, A6NNF4, A8MQ14, A8MTY0, E9QAG8, O75290, O75373, P08043, P0CJ79, P10751, P17017, P17027, P17039, P35789, P51522, P51523, Q08AN1, Q14585, Q14587, Q3SYV7, Q3ZCX4, Q4R4C7, Q52M93, Q5MCW4, Q5R5U3, Q5R8X1, Q5R9F0, Q5SXM1, Q6ECI4, Q6JLC9, Q6P3V2, Q6P5C7, Q6ZN57, Q86UE3, Q86XN6, Q86YE8, Q8C827, Q8IYB9, Q8N4W9, Q8N7M2
Diamond homologs: A0A1W2PQL4, A6NK75, A6NN14, A6NNF4, A6NP11, A8MQ14, A8MTY0, A8MUV8, A8MXY4, B4DX44, B4DXR9, E9PYI1, E9Q8G5, O14628, O43345, O60765, O75290, O75346, O75373, O75437, O95780, P0CB33, P0DKX0, P0DPD5, P10078, P17019, P17038, P17039, P35789, P52738, P52744, Q03923, Q03924, Q03936, Q03938, Q05481, Q14586, Q14593, Q14929, Q15928
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
97 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 88 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
959 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:34927215:GC:G | donor_gain | 1.0000 |
| 19:34929957:G:GG | donor_gain | 1.0000 |
| 19:34931842:GAA:G | acceptor_gain | 1.0000 |
| 19:34931842:GAAAT:G | acceptor_gain | 1.0000 |
| 19:34931990:ATGG:A | donor_gain | 1.0000 |
| 19:34931990:ATGGG:A | donor_loss | 1.0000 |
| 19:34931991:TGG:T | donor_gain | 1.0000 |
| 19:34931991:TGGG:T | donor_loss | 1.0000 |
| 19:34931992:GG:G | donor_gain | 1.0000 |
| 19:34931992:GGG:G | donor_gain | 1.0000 |
| 19:34931992:GGGT:G | donor_loss | 1.0000 |
| 19:34931993:GG:G | donor_gain | 1.0000 |
| 19:34931993:GGT:G | donor_loss | 1.0000 |
| 19:34931994:G:GG | donor_gain | 1.0000 |
| 19:34931995:T:A | donor_loss | 1.0000 |
| 19:34933608:C:G | acceptor_gain | 1.0000 |
| 19:34933610:T:G | acceptor_gain | 1.0000 |
| 19:34943221:A:AG | acceptor_gain | 1.0000 |
| 19:34943222:G:GG | acceptor_gain | 1.0000 |
| 19:34927204:GAC:G | donor_gain | 0.9900 |
| 19:34927217:G:GG | donor_gain | 0.9900 |
| 19:34929872:T:TA | acceptor_gain | 0.9900 |
| 19:34929873:G:A | acceptor_gain | 0.9900 |
| 19:34929882:A:AG | acceptor_gain | 0.9900 |
| 19:34929883:G:GG | acceptor_gain | 0.9900 |
| 19:34929883:GCTTT:G | acceptor_gain | 0.9900 |
| 19:34929954:CATGT:C | donor_loss | 0.9900 |
| 19:34929956:TG:T | donor_loss | 0.9900 |
| 19:34929957:G:C | donor_loss | 0.9900 |
| 19:34929958:T:A | donor_loss | 0.9900 |
AlphaMissense
4145 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:34944191:T:C | F409L | 0.994 |
| 19:34944193:T:A | F409L | 0.994 |
| 19:34944193:T:G | F409L | 0.994 |
| 19:34944611:T:C | F549L | 0.994 |
| 19:34944613:T:A | F549L | 0.994 |
| 19:34944613:T:G | F549L | 0.994 |
| 19:34943855:T:C | F297L | 0.993 |
| 19:34943857:T:A | F297L | 0.993 |
| 19:34943857:T:G | F297L | 0.993 |
| 19:34944527:T:C | F521L | 0.993 |
| 19:34944529:C:A | F521L | 0.993 |
| 19:34944529:C:G | F521L | 0.993 |
| 19:34943939:T:C | F325L | 0.992 |
| 19:34943941:C:A | F325L | 0.992 |
| 19:34943941:C:G | F325L | 0.992 |
| 19:34944023:T:C | F353L | 0.992 |
| 19:34944025:T:A | F353L | 0.992 |
| 19:34944025:T:G | F353L | 0.992 |
| 19:34944359:T:C | F465L | 0.992 |
| 19:34944361:C:A | F465L | 0.992 |
| 19:34944361:C:G | F465L | 0.992 |
| 19:34944695:T:C | F577L | 0.992 |
| 19:34944697:T:A | F577L | 0.992 |
| 19:34944697:T:G | F577L | 0.992 |
| 19:34944107:T:C | F381L | 0.991 |
| 19:34944109:C:A | F381L | 0.991 |
| 19:34944109:C:G | F381L | 0.991 |
| 19:34944275:T:C | F437L | 0.990 |
| 19:34944277:T:A | F437L | 0.990 |
| 19:34944277:T:G | F437L | 0.990 |
dbSNP variants (sampled 300 via entrez): RS1000067119 (19:34924173 A>C), RS1000138655 (19:34925486 C>T), RS1000174088 (19:34943080 T>G), RS1000247261 (19:34942725 G>C), RS1000254528 (19:34937001 G>T), RS1000314817 (19:34942445 A>G), RS1000483398 (19:34936467 G>A,T), RS1000484142 (19:34944735 A>G), RS1000516327 (19:34944573 G>A), RS1000579247 (19:34941378 C>T), RS1000622009 (19:34937985 G>A), RS1000782662 (19:34936094 C>T), RS1000806813 (19:34935102 G>C), RS1001054739 (19:34941173 C>G,T), RS1001079513 (19:34932868 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006993_14 | Hippocampal volume in Alzheimer’s disease dementia | 6.000000e-07 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005035 | hippocampal volume |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
35 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Tetrachlorodibenzodioxin | decreases expression | 2 |
| Cadmium Chloride | decreases expression, increases abundance, increases expression | 2 |
| dicrotophos | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| alpha-pinene | affects cotreatment, increases oxidation, increases abundance | 1 |
| bisphenol A | decreases methylation | 1 |
| beta-lapachone | increases expression, decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| methacrylaldehyde | increases abundance, affects cotreatment, increases oxidation | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| nutlin 3 | increases expression, affects cotreatment | 1 |
| abrine | decreases expression | 1 |
| bisphenol S | decreases methylation | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Acrolein | affects cotreatment, increases oxidation, increases abundance | 1 |
| Air Pollutants | affects cotreatment, increases abundance, increases oxidation | 1 |
| Atrazine | decreases expression | 1 |
| Benzo(a)pyrene | increases methylation, affects methylation | 1 |
| Cadmium | increases expression, increases abundance | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Dactinomycin | affects cotreatment, increases expression | 1 |
| Ozone | increases oxidation, increases abundance, affects cotreatment | 1 |
| Potassium Chloride | decreases expression, decreases response to substance | 1 |
| Quercetin | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Dronabinol | decreases expression, decreases response to substance | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.